The University of Lübeck is a research university in Lübeck, Northern Germany which focuses almost entirely on medicine and sciences with applications in medicine.

During the past decade, Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein" #1 collaborator was "Zealand University Hospital" with 2 trials as a collaborator, "Design School Kolding" with 1 trials as a collaborator, "EUROIMMUN Medizinische Labordiagnostika AG" with 1 trials as a collaborator and "European Regional Development Fund" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein" are "Age-Related Macular Degeneration" (2 trials), "Retinitis Pigmentosa" (2 trials), "Breast Cancer Female" (1 trials), "Coronary Artery Disease" (1 trials) and "Evaluation of New Tissue Biomarkers for Cervical Cancer" (1 trials). Many other conditions were trialed in "Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein" in a lesser frequency.

Most popular intervention types in "Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein" are "Device" (2 trials), "Diagnostic Test" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lucentis (Ranibizumab)" (2 trials), "Argus II Retinal Prosthesis" (1 trials), "Mepitel® Film" (1 trials), "Standard Care" (1 trials) and "determination of dynamic preload variables" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein" are 8 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein". 1 are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".